Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug.

Journal of Bioenergetics and Biomembranes
Simone CardaciMaria Rosa Ciriolo

Abstract

The Warburg effect refers to the phenomenon whereby cancer cells avidly take up glucose and produce lactic acid under aerobic conditions. Although the molecular mechanisms underlying tumor reliance on glycolysis remains not completely clear, its inhibition opens feasible therapeutic windows for cancer treatment. Indeed, several small molecules have emerged by combinatorial studies exhibiting promising anticancer activity both in vitro and in vivo, as a single agent or in combination with other therapeutic modalities. Therefore, besides reviewing the alterations of glycolysis that occur with malignant transformation, this manuscript aims at recapitulating the most effective pharmacological therapeutics of its targeting. In particular, we describe the principal mechanisms of action and the main targets of 3-bromopyruvate, an alkylating agent with impressive antitumor effects in several models of animal tumors. Moreover, we discuss the chemo-potentiating strategies that would make unparalleled the putative therapeutic efficacy of its use in clinical settings.

References

Oct 16, 1978·Biochemical and Biophysical Research Communications·H P MelocheR A Hogue-Angeletti
Nov 15, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·C W Conroy, T H Maren
Dec 10, 1973·Biochemical and Biophysical Research Communications·G G Chang, R Y Hsu
Nov 1, 1969·European Journal of Biochemistry·J P Baker, B R Rabin
Feb 10, 1971·Biochimica Et Biophysica Acta·B M SanbornT C Hollocher
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·H ShimC V Dang
Mar 10, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M De LenaA Mazzei
Dec 26, 2001·The Journal of Biological Chemistry·John G PastorinoJan B Hoek
Mar 16, 2002·Journal of Applied Physiology·Grant B McClelland, George A Brooks
Aug 16, 2002·The New England Journal of Medicine·George D DemetriHeikki Joensuu
Jun 20, 2003·Journal of Neuro-oncology·Stéphane OudardJean Y Delattre
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hui LiSanford D Markowitz
Feb 24, 1956·Science·O WARBURG
Oct 25, 2003·Oncogene·Suresh V AmbudkarMichael M Gottesman
Nov 12, 2003·American Journal of Clinical Pathology·Christian RudlowskiMarkus Moser
May 26, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Helene PelicanoPeng Huang
Jun 3, 2004·Cancer Research·Rebecca L ElstromCraig B Thompson
Sep 25, 2004·Journal of Cellular Physiology·Maria L MachedaJames D Best
Oct 7, 2004·Biochemical and Biophysical Research Communications·Young H KoPeter L Pedersen
Oct 8, 2004·The Biochemical Journal·Pablo StrobelFederico Leighton
Mar 2, 2005·Neoplasia : an International Journal for Oncology Research·Michael I KoukourakisUNKNOWN Tumor and Angiogenesis Research Group
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gary J KelloffDaniel C Sullivan
May 24, 2005·Seminars in Cancer Biology·Sybille MazurekErich Eigenbrodt
Jul 27, 2005·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Dinesh SinghViney Jain
Sep 10, 2005·Cell Death and Differentiation·G FilomeniM R Ciriolo
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Dec 8, 2006·The New England Journal of Medicine·Brian J DrukerUNKNOWN IRIS Investigators
Dec 21, 2006·Cancer Research·Muthusamy ThangarajuVadivel Ganapathy

❮ Previous
Next ❯

Citations

Sep 12, 2013·BioMed Research International·Zaira LeniAlexandre Arcaro
Feb 7, 2014·Endocrine-related Cancer·Ales VichaKarel Pacak
Jun 8, 2014·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Zhe-Yu HuYa Cao
Jan 29, 2014·Oncogene·L LeanzaI Szabo
Feb 29, 2016·Pharmacological Reports : PR·Izabela Sadowska-BartoszGrzegorz Bartosz
Mar 5, 2016·Nature Reviews. Rheumatology·Monica GumaGary S Firestein
Mar 1, 2014·IUBMB Life·Haibin XiTheodore J Lampidis
Jun 10, 2015·Journal of Bioenergetics and Biomembranes·Yiming SunHao Liu
May 21, 2014·The International Journal of Biochemistry & Cell Biology·Antonio Galina
Mar 1, 2013·Expert Opinion on Therapeutic Targets·George S KrasnovAnna V Kudryavtseva
Aug 30, 2013·Expert Opinion on Therapeutic Targets·George S KrasnovAnna V Kudryavtseva
Jul 4, 2015·Hormones & Cancer·Ivana JochmanováKarel Pacak
Jun 1, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Zhangfeng ZhongYitao Wang
Feb 14, 2015·Breast Cancer Research and Treatment·Qijin XuV Krishnan Ramanujan
Jul 19, 2014·Biochemical Pharmacology·Claudia CerellaMarc Diederich
Jan 28, 2016·Arthritis & Rheumatology·Ricard Garcia-CarbonellMonica Guma
Aug 19, 2016·Life Sciences·Izabela Sadowska-BartoszŁukasz Pułaski
Aug 18, 2016·Journal of Bioenergetics and Biomembranes·Ondřej SobotkaZuzana Červinková
Dec 17, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Paweł LisStanisław Ułaszewski
Dec 17, 2016·Acta Cirúrgica Brasileira·Qiong PanSurong Zhao
Jun 17, 2015·Antimicrobial Agents and Chemotherapy·Loyze Paola O de LimaHelene S Barbosa
Oct 27, 2018·Free Radical Research·Lukasz PulaskiIzabela Sadowska-Bartosz
Feb 25, 2014·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Leonor Côrte-RealFernanda Marques
Dec 31, 2015·Journal of Bioenergetics and Biomembranes·Ewa KwiatkowskaIzabela Sadowska-Bartosz
Nov 2, 2013·American Journal of Physiology. Gastrointestinal and Liver Physiology·Phuntila TharabenjasinRonaldo P Ferraris
Apr 3, 2014·Physiological Reviews·Ildiko Szabo, Mario Zoratti
Jan 1, 2018·Functional Plant Biology : FPB·Vadim DemidchikOlga V Voitsekhovskaja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Bacterial Respiration

This feed focuses on cellular respiration in bacteria, known as bacterial respiration. Discover the latest research here.